Differences of the Postoperative Outcome for Carotid Surgery Patients Treated by Either Male or Female Surgeons

June 26, 2024 updated by: University Hospital Augsburg
This research will focus on the differences of the postoperative outcome for carotid surgery patients treated by either male or female surgeons. Since 2012, in Germany, the surgical treatment of carotid stenosis has an established quality assurance, making the thematic especially suitable for testing the surgical results of either male or female surgeons.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Data about physician gender having impact on the treatment quality of a patient first appeared in 1999, the publication being about patients with breast cancer. This discussion was resumed in 2016 when Y. Tsugawa et. al showed that female doctors have, in comparison to male doctors, better treatment results. Primary outcomes for the study were mortality and readmissions, which were lower if the treatment has been done by a female doctor. Until today, there are only a few reports about the role of physician gender, especially that of surgeons, in the treatment quality. Studies like the ones from Blohm et. al and Wallis et. al show that female surgeons have a better outcome and a lower mortality, 30 days after the surgery. Wallis et. al also showed that the correlation between male surgeons and female patients have the worst results].

None of the studies that were written until today focussed on carotid surgery. Since 2012, in Germany, the surgical treatment of carotid stenosis has an established quality assurance, with specific documentation and a standard surgical course of action. This is why we consider that this surgery is especially suitable for comparison of results, depending on surgeon genders.

Study Type

Observational

Enrollment (Estimated)

800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Augsburg, Germany, 86156
        • University Hospital Augsburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

A retrospective data collection will be conducted for all the patients, that between jan. 2012 and dec. 2023, were operated because of a carotid stenosis in the University Clinic for Vascular and Endovascular Surgery in Augsburg. This stenosis may have been symptomatic or asymptomatic. The surgery must respect the latest quality assurance for that period.

Description

Inclusion Criteria:

  • Age above 18 years
  • All the patients that had a carotid revascularisation between jan. 2012 and dec. 2023.

Exclusion Criteria:

- No quality assurance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients undergoing surgery
A retrospective data collection will be conducted for all the patients, that between jan. 2012 and dec. 2023, were operated because of a carotid stenosis in the University Clinic for Vascular and Endovascular Surgery in Augsburg. This stenosis may have been symptomatic or asymptomatic. The surgery must respect the latest quality assurance for that period.
Carotid Surgery in patients with symptomatic or asymptomatic stenosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The impact of surgeons' gender, team gender and patients gender on postoperative apoplexy
Time Frame: 0-30 days
stroke [observed in a time frame of 30 days after the operation]
0-30 days
The impact of surgeons' gender team gender and patients gender on postoperative peripheral nerve lesions
Time Frame: 0-30 days
Impairment of peripheral cervial nerves [observed in a time frame of 30 days after the operation]
0-30 days
The impact of surgeons' gender team gender and patients gender on reinterventions
Time Frame: 0-30 days
Number of patients with surgical revision
0-30 days
The impact of surgeons' gender team gender and patients gender on procedure related death
Time Frame: 0-30 days
Number of patients who died following surgery
0-30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The impact of surgeons' gender team gender and patients gender on procedure time
Time Frame: 0-30 days
Duration of surgery measured in minutes
0-30 days
The impact of surgeons' gender team gender and patients gender on the length of stay
Time Frame: 0-30 days
length of stay in days
0-30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Alexander Hyhlik-Duerr, Prof., University Hospital Augsburg Vascular Surgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Actual)

December 31, 2023

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

January 29, 2024

First Submitted That Met QC Criteria

June 26, 2024

First Posted (Actual)

July 3, 2024

Study Record Updates

Last Update Posted (Actual)

July 3, 2024

Last Update Submitted That Met QC Criteria

June 26, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

anonymous study design

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carotid Stenosis

Clinical Trials on Carotid Surgery in patients with symptomatic or asymptomatic stenosis

Subscribe